ECM
BSX icon

Evergreen Capital Management’s Boston Scientific BSX Stock Holding History

Evergreen Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Sell
7,543
-14,310
-65% -$777K 0.01% 1173
2026
Q1 		$1.37M Buy
21,853
+6,320
+41% +$506K 0.03% 401
2025
Q4 		$1.48M Buy
15,533
+6,736
+77% +$660K 0.03% 374
2025
Q3 		$859K Buy
8,797
+929
+12% +$96.2K 0.02% 447
2025
Q2 		$845K Buy
7,868
+327
+4% +$33.1K 0.03% 401
2025
Q1 		$761K Buy
7,541
+1,210
+19% +$122K 0.03% 383
2024
Q4 		$565K Buy
6,331
+106
+2% +$9.33K 0.02% 465
2024
Q3 		$522K Buy
6,225
+275
+5% +$21.7K 0.02% 484
2024
Q2 		$458K Buy
5,950
+1,315
+28% +$96.3K 0.02% 495
2024
Q1 		$317K Buy
4,635
+249
+6% +$16K 0.01% 602
2023
Q4 		$254K Buy
4,386
+176
+4% +$9.39K 0.01% 670
2023
Q3 		$222K Sell
4,210
-180
-4% -$9.44K 0.01% 666
2023
Q2 		$237K Buy
+4,390
New +$229K 0.01% 652

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Evergreen Capital Management's BSX Position: Q2 2026 in Review

Evergreen Capital Management reduced its Boston Scientific (BSX) stake by 65% in Q2 2026, selling an estimated $777K and leaving 7,543 shares worth $322K. The position accounts for 0.01% of the portfolio, ranked #1173.

Evergreen Capital Management first reported a position in BSX in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.48M in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Evergreen Capital Management held 7,543 shares of Boston Scientific worth $322K as of Q2 2026.
  • Evergreen Capital Management sold 14,310 Boston Scientific shares in Q2 2026, an estimated $777K.
  • Boston Scientific made up 0.01% of Evergreen Capital Management's portfolio in Q2 2026, its #1173 holding.
  • Evergreen Capital Management first reported a position in Boston Scientific in Q2 2023 and has held it in 13 quarters since.
  • Evergreen Capital Management's Boston Scientific position peaked at $1.48M in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.